Q4 2024 Redwire Corp Earnings Call Transcript
Key Points
- Redwire Corp (RDW) achieved approximately 25% revenue growth in 2024, reaching a record annual revenue of $304.1 million.
- The company successfully expanded its production capabilities, increasing the number of ROSA Arrays under contract by 23.8% year-over-year.
- Redwire Corp (RDW) launched 27 pillboxes for partners like Eli Lilly and Bristol Myers Squibb, advancing its microgravity manufacturing capabilities.
- The company expanded its global footprint by adding three new facilities, two in California and one in Poland.
- Redwire Corp (RDW) has a strong pipeline with an estimated $7.1 billion of identified opportunities, including $4.1 billion in proposals submitted in 2024.
- Redwire Corp (RDW) experienced a negative adjusted EBITDA of $9.2 million in Q4 2024 due to unfavorable net EAC adjustments.
- The company's book-to-bill ratio was 0.76 times for the year, indicating challenges in converting pipeline opportunities into backlog.
- Redwire Corp (RDW) faced a net loss impacted by significant non-routine activities, including a $49.9 million increase in loss from non-cash warrant liability adjustments.
- The company recorded a $17.7 million net unfavorable EAC adjustment, affecting revenue recognition and profitability.
- Despite positive cash flow in Q4 2024, Redwire Corp (RDW) had a full-year use of cash from operations totaling $17.3 million.
Greetings and welcome to the Redwire Corporation Q4 and full year 2024 earnings call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce Jeffrey Zeunik, SVP Financial Planning and Analysis.
Thank you. You may begin.
Good morning and thank you, Darryl. Welcome to Redwire's fourth quarter and full year 2024 earnings call. We hope that you've seen our earnings release which we issued yesterday afternoon. It has also been posted in the Investor Relations section of our website at redwirespace.com.
Let me remind everyone that during the call, Redwire management may make forward-looking statements that reflect our beliefs, expectations, intentions, or predictions of the future. Our forward-looking statements are subject to risks and uncertainties that are described in more detail on slide 3.
Additionally, to the extent we discuss non-GAAP measures during the call, please see slide 4, our earnings release or the investor presentation on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
